COMMUNIQUÉS West-GlobeNewswire

Milestone Scientific Schedules Second Quarter 2018 Conference Call
10/08/2018
LIVINGSTON, N.J., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced [...]
Orphazyme announces enrollment of first patient in Phase III clinical trial of arimoclomol for ALS
10/08/2018
Orphazyme A/S Company announcement No. 10/2018 Company Registration No. 32266355 Primary objective is to determine efficacy of chronic treatment with arimoclomol compared to placebo over 76 weeks Results expected in H1 [...]
Evan Leonard, MS, MMS, PA-C is Selected to the American Health Council’s Board of Physicians
10/08/2018
NEW YORK, Aug. 10, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Evan Leonard, MS, MMS, PA-C to its Board of Physicians for his outstanding contributions to the medical field. An assistant professor and [...]
Canada House Wellness Group Continues Strategic Transformation with the Announcement of Changes to its Board of Directors
10/08/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]
Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2019
10/08/2018
DUBLIN - August 10, 2018 - Medtronic plc (NYSE:MDT) announced today that it will report financial results for the first quarter of fiscal year 2019 on Tuesday, August 21, 2018. A news release will be issued at [...]
Spine Injury Solutions Schedules Second Quarter Fiscal Year 2018 Conference Call for August 15, 2018 at 10:30 a.m. EDT
10/08/2018
HOUSTON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), will hold an investor conference call on Wednesday, August 15, at 10:30 am (EDT) to discuss its financial results for Q2 Fiscal Year [...]
Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update
10/08/2018
SAN DIEGO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the second quarter ended June 30, 2018 and a business update. Dr. Dennis J. Carlo, [...]
Merus Announces Financial Results for the Second Quarter 2018 & Mid-year Operating Results
10/08/2018
MCLA-128 Phase 1/2 clinical data from the gastric cancer cohort will be presented at the European Society for Medical Oncology Congress in October 2018 UTRECHT, The Netherlands, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Merus N [...]
ASLAN Pharmaceuticals Completes Recruitment for Global Phase 2 Study for Varlitinib in First Line Gastric Cancer
10/08/2018
SINGAPORE, Aug. 10, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN) (TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]
Matinas BioPharma Reports Second Quarter 2018 Financial Results and Provides Corporate Update
10/08/2018
– Management intently focused on advancing proprietary and highly differentiated lipid nano-crystal platform delivery technology – – Multiple discussions with strategic partners remain ongoing – – Lead platform- [...]
XBiotech Highlights Quarterly Developments
10/08/2018
Company Provides Updated Overview on its Clinical, Discovery and Financial Position AUSTIN, Texas, Aug. 10, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) provided an update on recent corporate and other [...]
Cellectar Reports 2018 Second Quarter Financial Results and Provides Business Update
10/08/2018
MADISON, Wis., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB)(“Cellectar or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization [...]
BioSyent Schedules Q2 2018 Earnings Release for August 22, 2018
10/08/2018
TORONTO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30, 2018 on Wednesday, August 22, [...]
Solid Biosciences Reports Second Quarter 2018 Financial Results and Provides Business Update
10/08/2018
- IGNITE DMD Phase I/II Clinical Trial Patient Screening Has Resumed - CAMBRIDGE, Mass., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB) today reported financial results for the second quarter [...]
Verona Pharma plc : PDMR Dealing & Issue of Shares
10/08/2018
LONDON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
ADMA Biologics Reports Second Quarter 2018 Financial Results
10/08/2018
Key Regulatory & Manufacturing Milestones Achieved RAMSEY, N.J. and BOCA RATON, Fla., Aug. 10, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”) today announced its financial [...]
ReWalk Robotics to Report Second Quarter 2018 Financial Results on August 14, 2018
10/08/2018
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Aug. 10, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”) today announced that the Company will release its second quarter 2018 [...]
PLx Pharma Inc. Reports Second Quarter 2018 Results
10/08/2018
Announces that FDA has approved new name Vazalore for PLx’s next generation, novel aspirin HOUSTON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty [...]
Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
10/08/2018
LIVONIA, Mich., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, [...]

Pages